Intradialytic hypotension prevention by intermittent infusion HDF

Intradialytic hypotension prevention by intermittent infusion HDF - III study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000013816

Enrollment

100

Registered

2014-04-30

Start date

2014-05-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Kidney Failure

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: # On hemodialysis thrice weekly. # Frequent intradialytic hypotension episodes (systolic blood pressure drop greater than 20mmHg during HD, or intradialytic hypotensive episode that needs any treatment)

Exclusion criteria

Exclusion criteria: # Cardiovascular or cerebrovascular event in the last 3 month. # Obvious inflammatory diseases. # Obvious and active infective diseases # Systolic blood pressure rise over 150mmHg during HD. # On dialyser with membrane area of greater than 2.2 square-meter, or less than 0.8 square-meter. # On combination therapy with adsorptive device (e.g. Lixcel)

Design outcomes

Primary

Measure	Time frame
The change of blood pressure during hemodialysis (including frequency of measures for hypotension)	—

Countries

Japan

Contacts

Public ContactYutaka Koda

Koda Medical and Dialysis Clinic Department of Internal Medicine

ykodan@gmail.com0256-92-0001

Outcome results